InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
29%
T+90 mean return
-19.8%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by WIRTH PETER, Director. Director active across 3 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 15 filings have been recorded. Split: 3 buys · 1 sell. Total volume traded: €889k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
21,253 shares0American Depositary SharesSEC:0000905148-24-001752:0
4,000 shares0Common StockSEC:0000950170-24-070708:0
18,903 shares@ US$26.4534.1% of flowAmerican Depositary SharesSEC:0000950170-23-031102:0
4,000 shares0Common StockSEC:0001209191-23-033735:0
4,000 shares@ US$71.3618.8% of flowAmerican Depositary SharesSEC:0000899243-22-038230:0
Ideal exit: 4 Sept 2022 (T+270)
3,852 shares@ US$35.379.6% of flowAmerican Depositary SharesSEC:0000899243-22-038070:0
127,665 sharesCommon StockSEC:0000899243-22-033648:0
8,000 shares0Common StockSEC:0001209191-22-050561:0
4,500 shares0Common StockSEC:0000899243-22-021664:0
7,763 shares0Ordinary SharesSEC:0001567619-22-000400:0
7,763 shares0Ordinary SharesSEC:0001567619-22-000400
4,000 shares@ US$71.3618.8% of flowOrdinary SharesSEC:0001567619-21-021802
Ideal exit: 4 Sept 2022 (T+270)
4,000 shares@ US$71.360.011% mcap50.0% of flowOrdinary SharesSEC:0001567619-21-021802:0
Ideal exit: 4 Sept 2022 (T+270)
2,750 shares0Common StockSEC:0000899243-21-025089
2,750 shares0Common StockSEC:0000899243-21-025089:0
15 of 15 declarations
About WIRTH PETER
Peter Wirth is a Board Member at Forma Therapeutics Holdings, Inc. and Zai Lab Ltd. He brings valuable expertise in the biopharmaceutical sector. As a Board Member, he oversees the development and innovation strategies of these companies, contributing to their success in the market.
